Article Text

Download PDFPDF
Rapid proliferation of illegal pod-mod disposable e-cigarettes
  1. Cristine Delnevo1,2,
  2. Daniel P Giovenco3,
  3. Mary Hrywna1,2
  1. 1Rutgers Center for Tobacco Studies, Rutgers University, New Brunswick, New Jersey, USA
  2. 2Department of Health Behavior, Society & Policy, Rutgers School of Public Health, Piscataway, New Jersey, USA
  3. 3Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, New York, USA
  1. Correspondence to Dr Cristine Delnevo, Rutgers Center for Tobacco Studies, Rutgers University, New Brunswick, NJ 08901, USA; delnevo{at}rutgers.edu

Statistics from Altmetric.com

Under pressure from the US Food and Drug Administration (FDA), JUUL Labs suspended sale of cucumber, crème, fruit and mango flavoured pods in US brick and mortar retail stores in November 2018 as part of the company’s plan to prevent youth e-cigarette use. Subsequently, mint flavour surged in popularity, against a backdrop of continued increases in youth e-cigarette prevalence.1 In October 2019, JUUL Labs halted sales of most of their flavoured pods, including mint, in retail stores and online, with the exception of menthol and tobacco. Other companies quickly capitalised on these actions and produced JUUL-compatible pods in a variety of flavours, including the most popular JUUL flavours (eg, mango, cucumber).2

In September 2019, we received anecdotal reports that a new vaping product—a disposable ‘pod-mod’, closely resembling JUUL—was popular among college students at a Kean university. We subsequently searched a sub-Reddit forum dedicated to JUUL to find mention of disposable ‘pod-mods’ which began appearing late Spring 2019. Brands mentioned in these threads included ‘Posh’, ‘Eon Stik’ and ‘Mr. Vapor,” and comments focused on tasting similar to JUUL flavours, lasting longer than …

View Full Text

Footnotes

  • Twitter @crisdelnevo, @dannygiovenco

  • Contributors CD conceived of the paper concept. CD, DPG and MH contributed to interpretation, writing and editing of the paper.

  • Funding Research reported in this publication was supported by the National Cancer Institute (http://dx.doi.org/10.13039/100007316) of the National Institutes of Health under Award Number U54CA229973.

  • Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement There are no data in this work

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.